E 1308: A phase II trial of induction chemotherapy (IC) followed by cetuximab with low dose versus standard dose IMRT in patients with human papilloma virus (HPV)-associated resectable squamous cell carcinoma of the oropharynx (OPSCC).
Year: 2013
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Johns Hopkins University, Dana-Farber Cancer Institute, Vanderbilt University Medical Center, The Ohio State University, UPMC Hillman Cancer Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Northwestern University, Colorado Cancer Research Program, HealthPartners, Stanford University, Fox Chase Cancer Center
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2401941104